These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1750018)

  • 1. Pulmonary deposition of nebulised amiloride in cystic fibrosis: comparison of two nebulisers.
    Thomas SH; O'Doherty MJ; Graham A; Page CJ; Blower P; Geddes DM; Nunan TO
    Thorax; 1991 Oct; 46(10):717-21. PubMed ID: 1750018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which apparatus for inhaled pentamidine? A comparison of pulmonary deposition via eight nebulisers.
    Thomas SH; O'Doherty MJ; Page CJ; Nunan TO; Bateman NT
    Eur Respir J; 1991 May; 4(5):616-22. PubMed ID: 1936233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pulmonary deposition of colistin aerosols in cystic fibrosis. Comparison of an ultrasonic nebulizer and a pneumatic nebulizer].
    Gagnadoux F; Diot P; Marchand S; Thompson R; Dieckman K; Lemarié E; Varaigne F; Maurage C; Baulieu JL; Rolland JC
    Rev Mal Respir; 1996; 13(1):55-60. PubMed ID: 8650418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct isotopic assessment of aerosolized pentamidine deposition: influence of nebuliser.
    Diot P; Le Pape A; Becquemin MH; Besnier JM; Boissinot E; Bastides F; Benjemaa M; Choutet P; Lemarie E
    Eur J Med; 1993; 2(8):484-8. PubMed ID: 8258049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebuliser systems for drug delivery in cystic fibrosis.
    Daniels T; Mills N; Whitaker P
    Cochrane Database Syst Rev; 2013 Apr; (4):CD007639. PubMed ID: 23633344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of nebulised antibiotic delivery in cystic fibrosis.
    Wilson D; Burniston M; Moya E; Parkin A; Smye S; Robinson P; Littlewood J
    Arch Dis Child; 1999 Apr; 80(4):348-52. PubMed ID: 10086942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy.
    App EM; King M; Helfesrieder R; Köhler D; Matthys H
    Am Rev Respir Dis; 1990 Mar; 141(3):605-12. PubMed ID: 2310093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of amiloride and saline on nasal mucociliary clearance and potential difference in cystic fibrosis and normal subjects.
    Middleton PG; Geddes DM; Alton EW
    Thorax; 1993 Aug; 48(8):812-6. PubMed ID: 8211871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis.
    Byrne NM; Keavey PM; Perry JD; Gould FK; Spencer DA
    Arch Dis Child; 2003 Aug; 88(8):715-8. PubMed ID: 12876172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Airway deposition and clearance and systemic pharmacokinetics of amiloride following aerosolization with an ultrasonic nebulizer to normal airways.
    Noone PG; Regnis JA; Liu X; Brouwer KL; Robinson M; Edwards L; Knowles MR
    Chest; 1997 Nov; 112(5):1283-90. PubMed ID: 9367469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary deposition of nebulised pentamidine isethionate: effect of nebuliser type, dose, and volume of fill.
    O'Doherty M; Thomas S; Page C; Bradbeer C; Nunan T; Bateman N
    Thorax; 1990 Jun; 45(6):460-4. PubMed ID: 2392791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary deposition of aerosolised pentamidine using a new nebuliser: efficiency measurements in vitro and in vivo.
    Ferretti PP; Versari A; Gafà SI; Becquemin MH; Barchi E; Serafini D; Roy M; Salvo D; Bouchikhi A
    Eur J Nucl Med; 1994 May; 21(5):399-406. PubMed ID: 8062844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary deposition of a nebulised aerosol during mechanical ventilation.
    Thomas SH; O'Doherty MJ; Fidler HM; Page CJ; Treacher DF; Nunan TO
    Thorax; 1993 Feb; 48(2):154-9. PubMed ID: 8493630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung deposition after inhalation with various nebulisers in preterm infants.
    Köhler E; Jilg G; Avenarius S; Jorch G
    Arch Dis Child Fetal Neonatal Ed; 2008 Jul; 93(4):F275-9. PubMed ID: 18192330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA; McDonald V
    Cochrane Database Syst Rev; 2000; (2):CD001506. PubMed ID: 10796798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a spacer on pulmonary aerosol deposition from a jet nebuliser during mechanical ventilation.
    Harvey CJ; O'Doherty MJ; Page CJ; Thomas SH; Nunan TO; Treacher DF
    Thorax; 1995 Jan; 50(1):50-3. PubMed ID: 7886649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deposition of amphotericin B aerosols in pulmonary aspergilloma.
    Diot P; Rivoire B; Le Pape A; Lemarie E; Dire D; Furet Y; Breteau M; Smaldone GC
    Eur Respir J; 1995 Aug; 8(8):1263-8. PubMed ID: 7489788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A widely available method for the assessment of aerosol delivery in cystic fibrosis.
    Kastelik JA; Wright GA; Aziz I; Davies M; Avery GR; Paddon AJ; Howey S; Morice AH
    Pulm Pharmacol Ther; 2002; 15(6):513-9. PubMed ID: 12493338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung Deposition of Alpha1-Proteinase Inhibitor (Human) (A1-PI[H]) Inhalation Solution Using Two Inhalation Modes of the I-neb Adaptive Aerosol Delivery (AAD) System in Healthy Subjects and Subjects with Cystic Fibrosis.
    Häussermann S; Winnips C; Edelman J; Kappeler D; Herpich C; Ehlich H; Zanker D; Kietzig C; Sommerer K
    J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):242-50. PubMed ID: 26669827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern.
    Newman SP; Woodman G; Clarke SW
    Thorax; 1988 Apr; 43(4):318-22. PubMed ID: 3406919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.